•OKYO's urcosimod gets FDA nod, moves to global phase 3 trial for NCP•Registration opens for Eyes On Cataract & Refactive•Leukemia may appear in RVO prior to diagnosis•Peer-reviewed study supports Deseyne EDOF daily contact lens for presbyopia•FDA grants RMAT designation to Emmecell's CED cell therapy •OKYO's urcosimod gets FDA nod, moves to global phase 3 trial for NCP•Registration opens for Eyes On Cataract & Refactive•Leukemia may appear in RVO prior to diagnosis•Peer-reviewed study supports Deseyne EDOF daily contact lens for presbyopia•FDA grants RMAT designation to Emmecell's CED cell therapy
HEADLINES
FEATURED
Federal agency warns that Lupin’s generic of the prescription-based Pred Forte may have the presence of a foreign substance in its formulation.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
![[object Object]](/_next/image/?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F51cpf7jm%2Fproduction%2Fa59f0611b99f404a5cf253958bf4abff5320346c-1200x628.png%3Fw%3D2400%26q%3D100%26fit%3Dfill%26auto%3Dformat&w=3840&q=75)
